Drug Profile
Cizolirtine
Alternative Names: E 4960; E 4961; E-4018Latest Information Update: 24 Jun 2015
Price :
$50
*
At a glance
- Originator Esteve
- Class Non-opioid analgesics; Pyrazoles; Small molecules
- Mechanism of Action Calcitonin gene-related peptide antagonists; Substance P release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Overactive bladder; Pain; Stress incontinence; Urinary incontinence
Most Recent Events
- 24 Feb 2010 Cizolirtine is still in active development for Overactive bladder and Urinary incontinence
- 29 Mar 2006 Esteve has completed enrolment in a phase II trial for Stress urinary incontinence in Europe
- 28 Feb 2005 Phase-II clinical trials in Stress urinary incontinence in Europe (unspecified route)